This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dr. Martin Silverstein Named WellPoint’s Chief Strategy Officer

WellPoint, Inc. (NYSE: WLP) announced today Martin Silverstein, M.D., has been named chief strategy officer, effective April 28th. In this role, Dr. Silverstein will oversee WellPoint’s enterprise marketing, corporate development and strategy functions, and will be responsible for short and long-term strategic planning to ensure the Company is maximizing the value of its assets and capturing growth across its geographies and businesses.

“Marty brings broad health care sector expertise to the role, and is respected throughout the industry for advancing innovative business solutions at the intersection of managed care, care delivery, pharmacy, and health care reform,” said Joseph R. Swedish, WellPoint’s chief executive officer. “His leadership and experience will be critical as we refine and advance our strategies to further our position as a valued health partner and leading health benefits company.”

Dr. Silverstein joins WellPoint from The Boston Consulting Group (BCG) where he was a Senior Partner and Managing Director. In his more than twenty-five years at BCG, Dr. Silverstein has held many leadership roles from establishing its U.S. Payers and Providers sector and having led the firm's Global Health Care Practice. He has consulted to clients in most sectors of the health care industry, including managed care organizations, integrated delivery and hospital systems, biopharmaceutical manufacturers, and retail pharmacies. Before joining BCG he worked as a physician in private and corporate practice and as a senior scientist and project manager at the Health Data Institute.

Dr. Silverstein holds a medical degree from the Yale University School of Medicine and is board certified in internal medicine. He received his MBA from Harvard Business School, and earned his bachelor’s degree in economics and natural sciences from the University of Pennsylvania.

About WellPoint, Inc.

WellPoint is one of the nation’s leading health benefits companies. We believe that our health connects us all. So we focus on being a valued health partner and delivering quality products and services that give members access to the care they need. With nearly 68 million people served by our affiliated companies including nearly 36 million enrolled in our family of health plans, we can make a real difference to meet the needs of our diverse customers. We’re an independent licensee of the Blue Cross and Blue Shield Association. We serve members as the Blue Cross licensee for California; and as the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as the Blue Cross Blue Shield licensee in 10 New York City metropolitan and surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), and Wisconsin. In most of these service areas, our plans do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia and Empire Blue Cross Blue Shield, or Empire Blue Cross (in the New York service areas). We also serve customers in other states through our Amerigroup and CareMore subsidiaries. To find out more about us, go to wellpoint.com.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASDAQ 4,683.9190 -49.5780 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs